Treating Drug-Resistant Childhood Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Schizophrenia
Interventions
DRUG

Olanzapine

Participants will receive olanzapine for 12 weeks.

DRUG

Clozapine

Participants will receive 12 weeks of clozapine.

Trial Locations (3)

10461

Bronx Children's Psychiatric Center, The Bronx

11004

Long Island Jewish Medical Center, Glen Oaks

11746

Sagamore Children's Psychiatric Center, Dix Hills

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Northwell Health

OTHER

NCT00048828 - Treating Drug-Resistant Childhood Schizophrenia | Biotech Hunter | Biotech Hunter